IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Virtus Investment Advisers, LLC

Q2 2026 Holdings

Filed 2026-08-11 | 463 holdings | $429.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Damora Therapeutics Inc(GLTO)COM NEW36322Q206$409.6K15,7460.1%
Avalo Therapeutics Inc(AVTX)COM NEW05338F306$409.7K22,1680.1%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$409.8K27,4270.1%
Vera Therapeutics Inc(VERA)CL A92337R101$409.8K9,5500.1%
Bain Cap Specialty FIN Inc(BCSF)COM STK05684B107$410.8K32,8100.1%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$410.8K1,2270.1%
Relay Therapeutics Inc(RLAY)COM75943R102$413.4K22,0940.1%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$414.7K33,1500.1%
GH Research PLC(GHRS)ORDINARY SHARESG3855L106$416.4K15,4920.1%
Veradermics Inc(MANE)COMMON STOCK922967104$418.7K3,4060.1%
Zenas Biopharma Inc(ZBIO)COM98937L105$419.4K16,5250.1%
VOR Biopharma Inc(VOR)COM NEW929033207$419.5K22,7850.1%
Fidus Invt Corp(FDUS)COM316500107$419.6K22,0030.1%
Ideaya Biosciences Inc(IDYA)COM45166A102$420.8K11,2900.1%
Maplight Therapeutics Inc(MPLT)COM56565P103$422.6K11,7910.1%
Arcus Biosciences Inc(RCUS)COM03969F109$423.9K13,7480.1%
BlackRock Floating Rate Inc(BGT)COM091941104$424.0K39,7770.1%
Blackstone Secd Lending FD(BXSL)COMMON STOCK09261X102$424.1K17,8890.1%
Rezolute Inc(RZLT)COM NEW76200L309$425.4K81,8000.1%
Sana Biotechnology Inc(SANA)COM799566104$426.1K122,0890.1%
Erasca Inc(ERAS)COM29479A108$426.6K23,2880.1%
Xencor Inc(XNCR)COM98401F105$427.2K26,5370.1%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$428.5K39,5650.1%
Design Therapeutics Inc(DSGN)COM25056L103$431.6K29,8270.1%
Biohaven LTD(BHVN)COMG1110E107$431.6K29,0070.1%
KKR Income Opportunities FD(KIO)COM48249T106$431.7K38,3410.1%
Midcap Financial Invstmnt Co(MFIC)COM NEW03761U502$433.9K43,0450.1%
Monte Rosa Therapeutics Inc(GLUE)COM61225M102$434.2K17,9440.1%
Cullinan Therapeutics Inc(CGEM)COM230031106$434.9K23,8830.1%
Prime Medicine Inc(PRME)COM74168J101$435.1K117,9090.1%
Kymera Therapeutics Inc(KYMR)COM501575104$435.2K3,7950.1%
Nuveen CR Strategies Income(XJQCX)COM SHS67073D102$436.4K89,7890.1%
Ataibeckley Inc(ATAI)COM SHS04650F101$439.9K83,4690.1%
Pennantpark Floating Rate CA(PFLT)COM70806A106$440.8K58,9340.1%
Nuveen Floating Rate Income(JFR)COM67072T108$441.3K57,5390.1%
Viking Therapeutics Inc(VKTX)COM92686J106$444.0K11,3810.1%
Bioage Labs Inc(BIOA)COM09077V100$444.5K18,1370.1%
Oruka Therapeutics Inc(ORKA)COM687604108$445.5K4,6810.1%
Generate Biomedicines Inc(GENB)COM SHS370920100$445.9K26,4300.1%
Bicara Therapeutics Inc(BCAX)COM055477103$447.9K15,0860.1%
Intellia Therapeutics Inc(NTLA)COM45826J105$457.2K27,0190.1%
Solid Biosciences Inc(SLDB)COM NEW83422E204$457.8K45,8260.1%
Palvella Therapeutics Inc NE(PVLA)COM697947109$459.5K3,0070.1%
Meiragtx Hldgs PLC(MGTX)COMG59665102$460.9K34,1190.1%
Saratoga Invt Corp(SAR)COM NEW80349A208$463.1K20,7570.1%
Nurix Therapeutics Inc(NRIX)COM67080M103$468.3K19,3040.1%
Jade Biosciences Inc(JBIO)COM NEW008064206$473.9K21,3290.1%
FS Credit Opportunities Corp(FSCO)COMMON STOCK30290Y101$479.1K96,0050.1%
Aktis Oncology Inc(AKTS)COM01021M104$480.9K14,9200.1%
New MTN FIN Corp(NMFC)COM647551100$482.2K67,2540.1%
PreviousPage 5 of 10Next